-+ 0.00%
-+ 0.00%
-+ 0.00%

GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $478.367M Est

Benzinga·08/03/2026 20:19:12
Listen to the news
GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $478.367 million estimate.